Search for Clinical Trial Results
Lymphoma, T-Cell, Peripheral - 25 Studies Found
Status | Study |
Recruiting |
Study Name: Chidamide for Refractory/Relapsed Peripheral T Cell Lymphoma Condition: Peripheral T Cell Lymphoma Date: 2016-10-21 Interventions: Drug: Chidamide Chidamide is given to the patients as described, and drug concentration is measured in p |
Completed |
Study Name: E7777 for the Treatment of Patients With Peripheral T-Cell Lymphoma Condition: Peripheral T-Cell Lymphoma Date: 2011-07-18 Interventions: Biological: denileukin diftitox (E7777) E7777 will be administered by intravenous (IV) infusion for 5 da |
Active, not recruiting |
Study Name: Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry Condition: Peripheral T-cell Lymphoma Date: 2010-04-23 |
Not yet recruiting |
Study Name: Chidamide With ICE Regimen for Relapsed/Refractory Peripheral T Cell Lymphoma Condition: Peripheral T Cell Lymphoma Date: 2016-07-24 Interventions: Drug: Chidamide with ICE regimen Chidamide and ICE regimen, dosage described in arm description |
Recruiting |
Study Name: Chidamide Plus Chemotherapy in the Treatment of Peripheral T-cell Lymphoma Condition: Peripheral T Cell Lymphoma Date: 2016-04-19 Interventions: Drug: Chidamide |